We’re tracking in-house compensation. Take the Law360 Survey
Click here
Genentech, Inc. v. Sandoz Inc.
-
December 22, 2022
A Delaware federal judge rightly invalidated claims in a Roche unit's patents for a lung disease drug it paid $8 billion to acquire and properly held that a Novartis unit's generic version doesn't infringe, the Federal Circuit said Thursday.
-
October 04, 2022
Two judges in a Federal Circuit panel on Tuesday seemed unpersuaded by an argument from Roche unit Genentech Inc. that a Delaware federal judge wrongly let Sandoz Inc. off the hook for infringing patents on the pulmonary fibrosis drug Esbriet.
-
September 29, 2022
Two of the largest tobacco companies in the world head to the Federal Circuit to fight over a ban R.J. Reynolds won at the U.S. International Trade Commission that blocked Philip Morris from importing IQOS-branded heated tobacco products into the U.S. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.
-
May 09, 2022
The Federal Circuit has refused to block Sandoz from launching a generic version of pulmonary fibrosis drug Esbriet, rejecting Genentech's bid for an injunction during an appeal in litigation involving the companies.